ConductScience.org, home

Paper33718985

Chronic Myelogenous Leukemia in Childhood.

Smith SM and 2 others. Curr Oncol Rep, 2021. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Chronic Myelogenous Leukemia in Childhood. Papers, record 33718985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33718985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chronic Myelogenous Leukemia in Childhood.
PubMed
Journal
Curr Oncol Rep
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
1.06
iCite
Revised in PubMed
2026-10-12
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith SMStephanie Mhttps://orcid.org/0000-0002-3369-7516
2Hijiya NNobuko
3Sakamoto KMKathleen M

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMajor topic
Protein Kinase InhibitorsMajor topic
Adolescent
Child
Dasatinib
Hematopoietic Stem Cell Transplantation
Humans
Imatinib Mesylate
Pyrimidines
Remission Induction

Source PubMed

Download CSV of topics

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118591451Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics.Circulation2008https://conductscience.org/library/papers/18591451PubMed
232734668A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia.Br J Haematol2020https://conductscience.org/library/papers/32734668PubMed
315537917Oligospermia in a patient receiving imatinib therapy for the hypereosinophilic syndrome.N Engl J Med2004https://conductscience.org/library/papers/15537917PubMed
423147254The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics.Leukemia2013https://conductscience.org/library/papers/23147254PubMed
523365461Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A.Blood2013https://conductscience.org/library/papers/23365461PubMed
629925908Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial.Leukemia2018https://conductscience.org/library/papers/29925908PubMed
729874142New Agents, Emerging Late Effects, and the Development of Precision Survivorship.J Clin Oncol2018https://conductscience.org/library/papers/29874142PubMed
830168243Temporal trends in the proportion of "cure" in children, adolescents, and young adults diagnosed with chronic myeloid leukemia in England: A population-based study.Pediatr Blood Cancer2018https://conductscience.org/library/papers/30168243PubMed
912006504Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.Clin Cancer Res2002https://conductscience.org/library/papers/12006504PubMed
1032127639European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.Leukemia2020https://conductscience.org/library/papers/32127639PubMed
1128905209
Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls.
Clin Transl Oncol2018https://conductscience.org/library/papers/28905209PubMed
1226371140Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia.J Clin Oncol2015https://conductscience.org/library/papers/26371140PubMed
1329899367Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia.Leukemia2018https://conductscience.org/library/papers/29899367PubMed
1439976936The Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: A Review.JAMA Oncol2025https://conductscience.org/library/papers/39976936PubMed
1530944100The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia.Blood Adv2019https://conductscience.org/library/papers/30944100PubMed
1621298759Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy.Pediatr Blood Cancer2011https://conductscience.org/library/papers/21298759PubMed
1730267760Practice Patterns of Physician Treatment for Pediatric Chronic Myelogenous Leukemia.Biol Blood Marrow Transplant2019https://conductscience.org/library/papers/30267760PubMed
1832668374Ponatinib in childhood Philadelphia chromosome-positive leukaemias: an international registry of childhood chronic myeloid leukaemia study.Eur J Cancer2020https://conductscience.org/library/papers/32668374PubMed
1925459396Growth deceleration in children treated with imatinib for chronic myeloid leukaemia.Eur J Cancer2014https://conductscience.org/library/papers/25459396PubMed
2022052850Imatinib has adverse effect on growth in children with chronic myeloid leukemia.Pediatr Blood Cancer2012https://conductscience.org/library/papers/22052850PubMed

See all 62 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42548712Case Report: Chronic myeloid leukemia masquerading as essential thrombocythemia in a child: the imperative for early BCR::ABL1 testing in isolated thrombocytosis.Front Pediatr2026https://conductscience.org/library/papers/42548712PubMed
42352456Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free Remission.Cancers (Basel)2026https://conductscience.org/library/papers/42352456PubMed
39682300Biological Markers of Myeloproliferative Neoplasms in Children, Adolescents and Young Adults.Cancers (Basel)2024https://conductscience.org/library/papers/39682300PubMed
39005125Impact of Tyrosine Kinase Inhibitors (TKIs) on Growth in Children and Adolescents with Chronic Myeloid Leukemia: A Systematic Review.Curr Pharm Des2024https://conductscience.org/library/papers/39005125PubMed
37284518Pediatric Autologous Hematopoietic Stem Cell Transplantation: Safety, Efficacy, and Patient Outcomes. Literature Review.Pediatric Health Med Ther2023https://conductscience.org/library/papers/37284518PubMed
36948878[Study progress of tyrosine kinase inhibitor discontinuation in children with chronic myeloid leukemia].Zhonghua Xue Ye Xue Za Zhi2023https://conductscience.org/library/papers/36948878PubMed
35689379Penttinen syndrome-associated PDGFRB Val665Ala variant causes aberrant constitutive STAT1 signalling.J Cell Mol Med2022https://conductscience.org/library/papers/35689379PubMed
35531147Protective effect of Bosutinib with caspase inhibitors on human K562 cells.Saudi J Biol Sci2022https://conductscience.org/library/papers/35531147PubMed
34918996Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML.Pediatr Hematol Oncol2022https://conductscience.org/library/papers/34918996PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TXK7294PubTator's text mininghttps://conductscience.org/library/genes/7294

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33718985

GET https://conductscience.org/api/papers/v1/33718985/references?page=2